MetaADEDB 2.0 @ LMMD
Glycyrrhizic Acid
(LPLVUJXQOOQHMX-QWBHMCJMSA-N)
Structure
SMILES
O[C@@H]1[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@H]([C@@H]([C@H]2O)O)O)[C@H](O[C@@H]([C@H]1O)C(=O)O)O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C
Type(s)
Approved; Experimental
ATC code(s)
A05BA08
Molecular Formula:
C42H62O16
Molecular Weight:
822.932
Log P:
2.2456
Hydrogen Bond Acceptor:
16
Hydrogen Bond Donor:
8
TPSA:
267.04
CAS Number(s):
1405-86-3
Synonym(s)
1.
Glycyrrhizic Acid
2.
Glycyrrhizin
3.
Diammonium Glycyrrhizinate
4.
Dipotassium Glycyrrhizinate
5.
Glycyrrhizinic Acid
6.
Zinc Glycyrrhizate
7.
Acid, Glycyrrhizic
8.
Acid, Glycyrrhizinic
9.
Glycyrrhizate, Zinc
10.
Glycyrrhizinate, Diammonium
11.
Glycyrrhizinate, Dipotassium
External Link(s)
MeSHD019695
PubChem Compound14982
BindingDB50185127
ChEBI15939
CHEMBLCHEMBL441687
DrugBankDB13751
DrugCentral1325
IUPHAR/BPS Guide to PHARMACOLOGY4688
KEGGcpd:C02284
dr:D00157
Therapeutic Target DatabaseD0T8QB
ZINC96015174
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal rebound tendernessOFFSIDES
2Accidental overdoseOFFSIDES
3Acute kidney injury12969435CTD
4Alanine Aminotransferase IncreasedOFFSIDES
5Alcoholic IntoxicationOFFSIDES
6AlopeciaOFFSIDES
7Alveolar Soft Part SarcomaOFFSIDES
8Ammonia increasedOFFSIDES
9Ankle FractureOFFSIDES
10AnorexiaOFFSIDES
11ApathyOFFSIDES
12AscitesOFFSIDES
13Aspartate aminotransferase decreasedOFFSIDES
14AspergillosisOFFSIDES
15AuraOFFSIDES
16Bacillus infectionOFFSIDES
17Bacteria sputum identifiedOFFSIDES
18Band neutrophil percentage increasedOFFSIDES
19Beta 2 microglobulin urine increasedOFFSIDES
20Blood albumin decreasedOFFSIDES
21Blood alkaline phosphatase increasedOFFSIDES
22Blood amylase increasedOFFSIDES
23Blood chloride decreasedOFFSIDES
24Blood creatine phosphokinase increasedOFFSIDES
25Blood creatinine decreasedOFFSIDES
26Blood creatinine increasedOFFSIDES
27Blood glucose decreasedOFFSIDES
28Blood lactate dehydrogenase increasedOFFSIDES
29Blood sodium increasedOFFSIDES
30Blood urea increasedOFFSIDES
31BradycardiaOFFSIDES
32Brain Injuries31150628CTD
33BronchiectasisOFFSIDES
34Chemical and Drug Induced Liver Injury25016076
28549656
CTD
35Chemical and Drug Induced Liver Injury, Chronic19426721CTD
36Chemotherapeutic drug level increasedOFFSIDES
37Creatinine renal clearance decreasedOFFSIDES
38Deafness NeurosensoryOFFSIDES
39DehydrationOFFSIDES
40Depressed Level of ConsciousnessOFFSIDES
41Depressed moodOFFSIDES
42Dermatitis, Allergic Contact16945185CTD
43Diabetes InsipidusOFFSIDES
44Disease ProgressionOFFSIDES
45Disseminated Intravascular CoagulationOFFSIDES
46Drug level below therapeuticOFFSIDES
47Enterococcal infectionOFFSIDES
48EnterocolitisOFFSIDES
49Eosinophil percentage decreasedOFFSIDES
50Eosinophilic PneumoniaOFFSIDES
51Epidural AbscessOFFSIDES
52Erythema MultiformeOFFSIDES
53Euphoric moodOFFSIDES
54Fatty Liver22982774CTD
55Fungus culture positiveOFFSIDES
56Gamma-Glutamyltransferase IncreasedOFFSIDES
57Glioblastoma MultiformeOFFSIDES
58GlobulinuriaOFFSIDES
59Granulocyte count decreasedOFFSIDES
60Head titubationOFFSIDES
61Headache1823397CTD
62Hepatitis A2167349CTD
63Hepatitis BOFFSIDES
64Hepatitis COFFSIDES
65HypercapniaOFFSIDES
66HypoaldosteronismOFFSIDES
67Immunosuppressant drug levelOFFSIDES
68Implant site effusionOFFSIDES
69Implant site infectionOFFSIDES
70Instillation site painOFFSIDES
71Intentional drug misuseOFFSIDES
72Jejunal ulcerOFFSIDES
73Kidney Diseases21803049CTD
74Large intestine perforationOFFSIDES
75Liver AbscessOFFSIDES
76Liver carcinoma rupturedOFFSIDES
77Liver neoplasms19426721CTD
78Lymphocyte percentage decreasedOFFSIDES
79Lymphocyte stimulation test positiveOFFSIDES
80MalabsorptionOFFSIDES
81Malignant neoplasm progressionOFFSIDES
82Monocyte percentage increasedOFFSIDES
83Multiple drug overdose intentionalOFFSIDES
84Musculoskeletal PainOFFSIDES
85MyelodysplasiaOFFSIDES
86Nausea1823397CTD
87Necrosis22982774CTD
88Neuroleptic Malignant SyndromeOFFSIDES
89OsteoporosisOFFSIDES
90Pancreatic enzymes increasedOFFSIDES
91PleurisyOFFSIDES
92Post procedural infectionOFFSIDES
93Pulmonary Edema1823397CTD
94Pulmonary InfarctionOFFSIDES
95Pulmonary congestionOFFSIDES
96Renal abscessOFFSIDES
97RhabdomyolysisOFFSIDES
98RhinorrheaOFFSIDES
99SnoringOFFSIDES
100SpondylitisOFFSIDES
101Sudden deathOFFSIDES
102TheftOFFSIDES
103Tinea PedisOFFSIDES
104Upper respiratory tract inflammationOFFSIDES
105Ventricular FibrillationOFFSIDES
106Vomiting1823397CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.